Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Therapy01:28

Drug Therapy

232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
232
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

270
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
270
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

239
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
239
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

209
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
209
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

151
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
151

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA.

Science translational medicine·2026
Same author

Diversion of Arginine's dietary metabolic fate in proteinuric kidney disease.

Research square·2026
Same author

The importance of clinical context in evaluating algorithmic fairness: insights from a medication adherence prediction algorithm.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

A Framework for Risk-Based Implementation of Combination Therapy in CKD: Who, Why, When, and How?

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Monitoring of Clinics That Use Direct-to-Consumer Advertising for Off-Label Ketamine in the New York Metropolitan Area: A Cross-Sectional Systematic Web Search.

Fundamental & clinical pharmacology·2026
Same author

Burden of Residual Angina Among Older Adults With Ischemic Heart Disease in the United States: Findings From the RESILIENT Trial.

Circulation. Population health and outcomes·2026

相关实验视频

Updated: Jan 8, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.9K

测量多种药物的坚持使用指南导向医疗疗作为模型.

Eli Reynolds1, Xiyue Li2, Amrita Mukhopadhyay2,3

  • 1Department of Internal Medicine, New York University Langone Health.

medRxiv : the preprint server for health sciences
|December 18, 2025
PubMed
概括

测量心力衰竭患者使用覆盖日数比例 (PDC) 的药物坚持率显示出广泛的变化. 选择的PDC方法对指导方针导向医疗疗 (GDMT) 的坚持评估和临床结果解释产生重大影响.

关键词:
在GDMTT的GDMT.坚持性 坚持性心脏衰竭是因为心脏衰竭.药物治疗的坚持 药物治疗的坚持多种药物,多种药物.覆盖日数的比例.覆盖日数 (PDC) 的比例.

更多相关视频

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K
Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

8.2K

相关实验视频

Last Updated: Jan 8, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.9K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K
Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

8.2K

科学领域:

  • 心脏病学 心脏病学
  • 药物经济学 药物经济学
  • 医疗保健服务研究 医疗服务研究

背景情况:

  • 心力衰竭 (HF) 的管理需要复杂的药物治疗方案,称为指导方针导向医学疗法 (GDMT).
  • 由于缺乏黄金标准,评估多种HF药物的坚持是具有挑战性的.
  • 覆盖日数 (PDC) 的比例是药物坚持的常见指标.

研究的目的:

  • 为了比较七种不同的覆盖日比例 (PDC) 措施,以评估心力衰竭 (HF) 患者对多种指南导向医疗疗 (GDMT) 药物的坚持.
  • 评估这些各种PDC依从度和临床结果之间的关联.

主要方法:

  • 一项回顾性队列研究包括34603名心力衰竭患者,他们在2021年4月至2022年7月期间填写了GDMT处方.
  • 从电子健康记录和药房数据中得出了七项基于PDC的遵守措施.
  • 临床结果包括急诊室的访问,住院和死亡.

主要成果:

  • 在七个PDC措施中观察到广泛的遵守率,从最严格的 (每个) 措施的54%,到最不严格的 (至少一个) 措施的73%.
  • 随着更多的GDMT药物,坚持的变化增加了.
  • 在所有测量指标中,较高的PDC与更多的急诊室访问,住院和死亡有关.

结论:

  • 选择覆盖日数比例 (PDC) 测量方法显著影响心力衰竭患者在指导方针导向医疗疗 (GDMT) 中对药物坚持的评估.
  • 这种变化对政策,临床实践和干预策略有重大影响.
  • 需要进一步的研究,以建立一个标准化和验证的方法来测量多种药物的坚持.